AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2916716 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation games including role‐playing/group dynamics and modeling/training
Number of subjects: 136
Study 2916716 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 136
Study 1106204 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 0
Study 1106204 — intervention group
Group type: COMPARATOR
Intervention: High-estrogen contraceptives
Number of subjects: 0
Study 1106204 — intervention group
Group type: COMPARATOR
Intervention: Estrogen-free contraceptives
Number of subjects: 0
Study 30067590 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity and Motivation in Physical EDucation intervention
Number of subjects: 1173
Study 30067590 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 1173
Study 28210777 — intervention group
Group type: EXPERIMENTAL
Intervention: Biperiden (2.0 mg)
Number of subjects: 17
Study 28210777 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 17
Study 28210777 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of biperiden and ATD
Number of subjects: 17
Study 28210777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 25175303 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 mesh graft
Number of subjects: 72
Study 25175303 — intervention group
Group type: COMPARATOR
Intervention: sheet graft
Number of subjects: 72
Study 22906434 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 94
Study 22906434 — intervention group
Group type: COMPARATOR
Intervention: Lying back position
Number of subjects: 94
Study 22906434 — intervention group
Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 94
Study 21323911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cockroach immunotherapy (IT) with Periplaneta americana extract
Number of subjects: 50
Study 21323911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 18268187 — intervention group
Group type: COMPARATOR
Intervention: Low-dose apomorphine hydrochloride (12.5 microg/kg/h and 25 microg/kg/h every 2 hours)
Number of subjects: 14
Study 18268187 — intervention group
Group type: COMPARATOR
Intervention: High-dose apomorphine hydrochloride (50 microg/kg/h and 100 microg/kg/h every 2 hours)
Number of subjects: 14
Study 18268187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 17062800 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month weight loss program including diet, exercise, and orlistat
Number of subjects: 48
Study 17062800 — intervention group
Group type: COMPARATOR
Intervention: No intervention (controls)
Number of subjects: 48
Study 14510908 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (50 mg)
Number of subjects: 15
Study 14510908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 10945420 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Relearning Programme (MRP)
Number of subjects: 61
Study 10945420 — intervention group
Group type: COMPARATOR
Intervention: Bobath
Number of subjects: 61
Study 8826606 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics plus G‐CSF (5 micrograms/kg/day, s.c.)
Number of subjects: 119
Study 8826606 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics alone (ceftazidime, 2 g, i.v., every 8 h + amikacin 7.5 mg/kg, i.v., every 12 h)
Number of subjects: 119
Study 1421390 — intervention group
Group type: EXPERIMENTAL
Intervention: rhuGM‐CSF 250 micrograms/m2 daily by continuous infusion after ABMT
Number of subjects: 81
Study 1421390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 1421390 — intervention group
Group type: EXPERIMENTAL
Intervention: rhuGM‐CSF
Number of subjects: 81
Study 6721959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine anaesthesia
Number of subjects: 0
Study 6721959 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone and halothane anaesthesia (Control)
Number of subjects: 0
Study 29767227 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month exercise programme (3 times a week for 30 min)
Number of subjects: 100
Study 29767227 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 100
Study 26799145 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg three times a day
Number of subjects: 120
Study 26799145 — intervention group
Group type: COMPARATOR
Intervention: Control group (valacyclovir and acetaminophen only)
Number of subjects: 120
Study 25719344 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (3 g powdered ginger daily for 3 months)
Number of subjects: 0
Study 25719344 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose, daily for 3 months)
Number of subjects: 0
Study 23229846 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach-led group intervention
Number of subjects: 241
Study 23229846 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed DVD intervention
Number of subjects: 241
Study 23229846 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 241
Study 20869358 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma myeloperoxidase (MPO) levels measured prior to myocardial perfusion scintigraphy (MPS)
Number of subjects: 267
Study 20869358 — intervention group
Group type: EXPERIMENTAL
Intervention: MPO levels
Number of subjects: 267
Study 18439766 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy (PORT) in the observation arm
Number of subjects: 840
Study 18439766 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy (PORT) in the chemotherapy arm
Number of subjects: 840
Study 18439766 — intervention group
Group type: COMPARATOR
Intervention: Observation without PORT
Number of subjects: 840
Study 17030751 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Activity Log (MAL) treatment group
Number of subjects: 222
Study 17030751 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 222
Study 15895715 — intervention group
Group type: EXPERIMENTAL
Intervention: rhASB 1.0 mg/kg/week
Number of subjects: 7
Study 15895715 — intervention group
Group type: COMPARATOR
Intervention: rhASB 0.2 mg/kg/week
Number of subjects: 7
Study 15895715 — intervention group
Group type: EXPERIMENTAL
Intervention: rhASB (both doses)
Number of subjects: 7
Study 11683484 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 28
Study 11683484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 9392980 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg intramuscular triamcinolone acetonide
Number of subjects: 22
Study 9392980 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 mg intramuscular triamcinolone acetonide
Number of subjects: 22
Study 9392980 — intervention group
Group type: COMPARATOR
Intervention: Control group (previous year data)
Number of subjects: 22
Study 7699233 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol 0.3 g/kg bw per day
Number of subjects: 28
Study 7699233 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol 0.5 g/kg bw per day
Number of subjects: 28
Study 7699233 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 28
Study 2439861 — intervention group
Group type: EXPERIMENTAL
Intervention: Two cycles of chemotherapy followed by radiotherapy
Number of subjects: 75
Study 2439861 — intervention group
Group type: COMPARATOR
Intervention: Three cycles of chemotherapy alone
Number of subjects: 75
Study 30479286 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose MBI (150 MBq Tc-99m sestamibi; images acquired for 10 minutes per view)
Number of subjects: 60
Study 30479286 — intervention group
Group type: COMPARATOR
Intervention: Half-time MBI (300 MBq Tc-99m sestamibi; images acquired for 5 minutes per view)
Number of subjects: 60
Study 30479286 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose or half-time MBI
Number of subjects: 60
Study 28538071 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual bone scraper
Number of subjects: 25
Study 28538071 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic insert
Number of subjects: 25
Study 25808637 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin therapy
Number of subjects: 830
Study 25808637 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 830
Study 25808637 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator
Number of subjects: 830
Study 25808637 — intervention group
Group type: COMPARATOR
Intervention: Control (Saline)
Number of subjects: 830
Study 25808637 — intervention group
Group type: COMPARATOR
Intervention: Overall cohort
Number of subjects: 830
Study 25808637 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic intracranial hemorrhage
Number of subjects: 830
Study 24136301 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate (LE) gel 0.5%
Number of subjects: 813
Study 24136301 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 813
Study 21633719 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol combination (FSC) 100/50 mcg BID
Number of subjects: 231
Study 21633719 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 100 mcg BID
Number of subjects: 231
Study 18978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ab-Slide
Number of subjects: 22
Study 18978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal crunch
Number of subjects: 22
Study 18978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine double leg thrust
Number of subjects: 22
Study 18978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Side bridge
Number of subjects: 22
Study 16526203 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of micronized fenofibrate
Number of subjects: 9795
Study 16526203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9795
Study 12967068 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype powered toothbrush (new Crest SpinBrush, rippled bristle pattern)
Number of subjects: 20
Study 12967068 — intervention group
Group type: COMPARATOR
Intervention: Control powered toothbrush (original Crest SpinBrush, flat bristle profile)
Number of subjects: 20
Study 10355326 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural violence affecting blacks
Number of subjects: 1384
Study 10355326 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal and institutional violence
Number of subjects: 1384
Study 10355326 — intervention group
Group type: COMPARATOR
Intervention: Criminal violence
Number of subjects: 1384
Study 10355326 — intervention group
Group type: COMPARATOR
Intervention: Trust in crime-control institutions
Number of subjects: 1384
Study 10355326 — intervention group
Group type: COMPARATOR
Intervention: Authoritarian attitudes and norms
Number of subjects: 1384
Study 7709266 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 1200
Study 7709266 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 1200
Study 7709266 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroid injections
Number of subjects: 1200
Study 7709266 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction
Number of subjects: 1200
Study 7709266 — intervention group
Group type: EXPERIMENTAL
Intervention: Corsets
Number of subjects: 1200
Study 7709266 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed rest
Number of subjects: 1200
Study 7709266 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotic analgesics
Number of subjects: 1200
Study 1790087 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc acexamate (ZAC) 300 mg at single nocturnal dose
Number of subjects: 146
Study 1790087 — intervention group
Group type: COMPARATOR
Intervention: Magaldrate (MAG) 800 mg bid
Number of subjects: 146
Study 1790087 — intervention group
Group type: COMPARATOR
Intervention: Aceglutamide aluminium salt (AAL) 700 mg bid
Number of subjects: 146
Study 6166245 — intervention group
Group type: EXPERIMENTAL
Intervention: Human leukocyte interferon (5 to 7 days therapy)
Number of subjects: 0
Study 6166245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30095762 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg
Number of subjects: 110
Study 30095762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 30095762 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 110
Study 28899366 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity calorie expenditure (PACE) food labels
Number of subjects: 0
Study 28899366 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PACE labeling)
Number of subjects: 0
Study 25784587 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity locomotor training (70%-80% of heart rate reserve)
Number of subjects: 12
Study 25784587 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity locomotor training (30%-40% of heart rate reserve)
Number of subjects: 12
Study 25784587 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training first
Number of subjects: 12
Study 25784587 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity training first
Number of subjects: 12
Study 23619543 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Kinesio taping (KT)
Number of subjects: 38
Study 23619543 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesio taping (KT)
Number of subjects: 38
Study 20579524 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk (0.5 L/d) containing eicosapentaenoic acid, docosahexaenoic acid, oleic acid, vitamins A, B(6), E, and folic acid
Number of subjects: 72
Study 20579524 — intervention group
Group type: COMPARATOR
Intervention: Semiskimmed milk (0.5 L/d)
Number of subjects: 72
Study 19378582 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clonidine (2.5 microg.kg(‐1))
Number of subjects: 0
Study 19378582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16478764 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg) with metformin
Number of subjects: 59
Study 16478764 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene (100 mg) with metformin
Number of subjects: 59
Study 14556881 — intervention group
Group type: EXPERIMENTAL
Intervention: Damped sine wave monophasic transthoracic cardioversion
Number of subjects: 0
Study 14556881 — intervention group
Group type: COMPARATOR
Intervention: Truncated exponential biphasic transthoracic cardioversion
Number of subjects: 0
Study 10821990 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral day treatment plus abstinence contingent housing and work therapy (DT+)
Number of subjects: 110
Study 10821990 — intervention group
Group type: COMPARATOR
Intervention: Behavioral day treatment alone (DT)
Number of subjects: 110
Study 9032870 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiosurgery
Number of subjects: 25
Study 1816597 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-min exercise at 100 Watts (high exercise)
Number of subjects: 30
Study 1816597 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-min exercise at 25 Watts (low exercise)
Number of subjects: 30
Study 1816597 — intervention group
Group type: COMPARATOR
Intervention: 20-min no exercise (control)
Number of subjects: 30
Study 6339921 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0
Study 6339921 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 0
Study 3889759 — intervention group
Group type: COMPARATOR
Intervention: 5-FU alone (15 mg/kg)
Number of subjects: 30
Study 3889759 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with cyclophosphamide (20 mg/kg) and 5-FU (15 mg/kg)
Number of subjects: 30
Study 3889759 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss greater than 10%
Number of subjects: 30
Study 3889759 — intervention group
Group type: EXPERIMENTAL
Intervention: No weight loss
Number of subjects: 30
Study 30188171 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training (BPT)
Number of subjects: 343
Study 30188171 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 343
Study 30188171 — intervention group
Group type: COMPARATOR
Intervention: Information-Only Control (IOC)
Number of subjects: 343
Study 26762678 — intervention group
Group type: EXPERIMENTAL
Intervention: Mnemonic arm
Number of subjects: 27
Study 26762678 — intervention group
Group type: COMPARATOR
Intervention: Rote memorization arm
Number of subjects: 27
Study 24880449 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanate (875/125mg)
Number of subjects: 546
Study 24880449 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (1g)
Number of subjects: 546
Study 24880449 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 546
Study 23055587 — intervention group
Group type: EXPERIMENTAL
Intervention: Tempered chlorhexidine
Number of subjects: 30
Study 23055587 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tempered chlorhexidine
Number of subjects: 30
Study 23055587 — intervention group
Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 30
Study 20430912 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathy in the cranial field (single intervention)
Number of subjects: 29
Study 20430912 — intervention group
Group type: COMPARATOR
Intervention: Light pressure applied to the cranium (control group)
Number of subjects: 29
Study 20430912 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathy in the cranial field (treatment group)
Number of subjects: 29
Study 18468447 — intervention group
Group type: EXPERIMENTAL
Intervention: Robicsek technique
Number of subjects: 86
Study 18468447 — intervention group
Group type: COMPARATOR
Intervention: Conventional sternal closure
Number of subjects: 86
Study 15811060 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (SRP)
Number of subjects: 42
Study 15811060 — intervention group
Group type: COMPARATOR
Intervention: Oral hygiene instruction and professional tooth cleaning
Number of subjects: 42
Study 12055113 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking group W1 (55% VO(2)MAX, 1500 kcal/week)
Number of subjects: 121
Study 12055113 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking group W2 (45% VO(2)MAX, 1500 kcal/week)
Number of subjects: 121
Study 12055113 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking group W3 (55% VO(2)MAX, 1000 kcal/week)
Number of subjects: 121
Study 12055113 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking group W4 (45% VO(2)MAX, 1000 kcal/week)
Number of subjects: 121
Study 12055113 — intervention group
Group type: EXPERIMENTAL
Intervention: All exercise groups
Number of subjects: 121
Study 10604501 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based programme of strength and balance retraining exercises
Number of subjects: 213
Study 10604501 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study 8819807 — intervention group
Group type: EXPERIMENTAL
Intervention: Holter monitoring (HM) for 24 hours during common everyday activities and after suspending anti-ischemic therapy
Number of subjects: 99
Study 8819807 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with anamnestic evidence of myocardial infarction
Number of subjects: 99
Study 8819807 — intervention group
Group type: EXPERIMENTAL
Intervention: Holter monitoring in patients with stable angina, especially if elderly
Number of subjects: 99
Study 1758528 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) administered intravenously
Number of subjects: 0
Study 1758528 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) administered subcutaneously
Number of subjects: 0
Study 1758528 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (rhEPO) with albumin as preservative
Number of subjects: 0
Study 1758528 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (rhEPO) without albumin as preservative
Number of subjects: 0
Study 7202832 — intervention group
Group type: EXPERIMENTAL
Intervention: Mictral (3-day course)
Number of subjects: 0
Study 7202832 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin (7-day course)
Number of subjects: 0
Study 7202832 — intervention group
Group type: COMPARATOR
Intervention: Mictral and Ampicillin (both groups)
Number of subjects: 0
Study 31298632 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit e‐cigarette use anywhere message
Number of subjects: 2201
Study 31298632 — intervention group
Group type: COMPARATOR
Intervention: Explicit e‐cigarette use anywhere message
Number of subjects: 2201
Study 29726480 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (2 mg injected into the coronary artery)
Number of subjects: 120
Study 29726480 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (200 μg injected into the coronary artery)
Number of subjects: 120
Study 29726480 — intervention group
Group type: COMPARATOR
Intervention: Control (PCI and balloon pre-dilation only)
Number of subjects: 120
Study 25434645 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHD) spray on umbilical cord three times a day for three days after cord fall
Number of subjects: 140
Study 25434645 — intervention group
Group type: COMPARATOR
Intervention: Routine umbilical cord care (control group)
Number of subjects: 140
Study 24266715 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4-8 mg
Number of subjects: 51
Study 24266715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 22116543 — intervention group
Group type: EXPERIMENTAL
Intervention: Mephenamic acid microspheres (250 mg)
Number of subjects: 4
Study 22116543 — intervention group
Group type: COMPARATOR
Intervention: Ponstan® capsule (250 mg)
Number of subjects: 4
Study 20670466 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF; 20-30% of energy)
Number of subjects: 106
Study 20670466 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA diet (MUFA; 35-45% of energy; >20% of fat as MUFA)
Number of subjects: 106